CASPR (@caspr_research) 's Twitter Profile
CASPR

@caspr_research

Center for Addiction, Science, Policy, and Research, CASPR.org Advancing breakthroughs and innovation for substance use disorders.
Subscribe to our substack!

ID: 1866240641317138432

linkhttps://recursiveadaptation.com calendar_today09-12-2024 21:57:05

29 Tweet

67 Takipçi

78 Takip Edilen

Anand Muthusamy (@mu_anand) 's Twitter Profile Photo

Excellent call to action re: addiction & biotech. Yes, drugs meant to affect behavior are challenging on all levels...all the more reasons to improve how they are designed and distributed today. ~750k deaths/year in the U.S. is staggering.

David Moore (@ppolitics) 's Twitter Profile Photo

A new nonprofit, CASPR (the Center for Addiction Science, Policy, and Research), is out with a sweeping policy agenda. (Consider the vast serious costs of the opioid crisis, times other substances.) All the info: recursiveadaptation.com/p/an-innovatio…

CASPR (@caspr_research) 's Twitter Profile Photo

Our addiction predictions for 2025 and beyond: GLP-1 micro-dosing, non-opioid painkillers, alcohol trends, and more. recursiveadaptation.com/p/addiction-pr…

Our addiction predictions for 2025 and beyond: GLP-1 micro-dosing, non-opioid painkillers, alcohol trends, and more.

recursiveadaptation.com/p/addiction-pr…
CASPR (@caspr_research) 's Twitter Profile Photo

"The Harm Reduction Promise of GLP-1s" CASPR Cofounder Nicholas Reville will be speaking at this event at Cato Institute on January 24. Please join us, in person or online. Registration is open. cato.org/events/harm-re…

Jennifer Doleac (@jenniferdoleac) 's Twitter Profile Photo

It's very cool to see what CASPR is doing to spur innovation in the treatment of substance use disorders (e.g. GLP-1s). Check out some of their recent activities: recursiveadaptation.com/p/glp-1-event-…

CASPR (@caspr_research) 's Twitter Profile Photo

CASPR Executive Director Nicholas Reville is on the Chris Hayes podcast today, hope you will listen! iOS: podcasts.apple.com/us/podcast/why… Spotify: open.spotify.com/episode/1pln27…

CASPR (@caspr_research) 's Twitter Profile Photo

Please join us in person or online at this free Cato Institute event on Jan 24th. Nicholas Reville will be speaking about GLP-1s and innovation in addiction medicine, moderated by Dr. Jeffrey Singer, Jeffrey A. Singer. Register free here: cato.org/events/harm-re…

CASPR (@caspr_research) 's Twitter Profile Photo

GLP-1s and addiction, "cravings are a more specific and more helpful way to look at what’s happening in addiction. And if you reduce those cravings, you can give people a chance, some space in their lives to address the other patterns, the other circumstances that have led them

CASPR (@caspr_research) 's Twitter Profile Photo

*starting in 10 minutes* join the livestream to hear Nicholas Reville speak about the transformative implications of GLP-1s for addiction treatment, and policies to improve affordability and access for those who need them.

CASPR (@caspr_research) 's Twitter Profile Photo

CASPR, and our research on GLP-1s for opioid use disorder, got a shout-out in this fascinating convo between Naval and Chris Williamson . They discussed the ideas that will shape the future, and call out GLP-1s to treat addiction. 5:30 for Naval's shout-out!